The results confirmed the hypothesis; thus, despite the obvious differences between patients and animal models overexpressing just one of the at-risk genetic mutations, this evidence supports the emerging paradigm of ALS as a multi-step disease and provides additional predictability to one of the most used ALS mouse models, which is the SOD1 transgenic mouse. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.